3 December, 2021 by The TZ Newswire Staff Comments Off on TrueCar, Inc. (NASDAQ:TRUE) Short Interest Down 19.6% in November
TrueCar, Inc. (NASDAQ:TRUE) Short Interest Down 19.6% in November
TrueCar, Inc. (NASDAQ:TRUE) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 5,580,000 shares, a decline of 19.6% from the October 31st total of 6,940,000 shares. Approximately 6.6% of the shares of the stock are short sold. Based on an average daily volume of 639,100 shares, the short-interest ratio is presently 8.7 days.
3 December, 2021 by The TZ Newswire Staff Comments Off on ManTech International Co. (NASDAQ:MANT) Short Interest Update
ManTech International Co. (NASDAQ:MANT) Short Interest Update
ManTech International Co. (NASDAQ:MANT) saw a large decrease in short interest in November. As of November 15th, there was short interest totalling 329,800 shares, a decrease of 19.5% from the October 31st total of 409,700 shares. Currently, 1.2% of the company’s stock are short sold. Based on an average daily trading volume, of 128,200 shares, the days-to-cover ratio is presently 2.6 days.
3 December, 2021 by The TZ Newswire Staff Comments Off on OrganiGram Holdings Inc. to Post FY2022 Earnings of ($0.09) Per Share, Jefferies Financial Group Forecasts (TSE:OGI)
OrganiGram Holdings Inc. to Post FY2022 Earnings of ($0.09) Per Share, Jefferies Financial Group Forecasts (TSE:OGI)
3 December, 2021 by The TZ Newswire Staff Comments Off on FY2022 Earnings Estimate for ImmunoGen, Inc. Issued By Jefferies Financial Group (NASDAQ:IMGN)
FY2022 Earnings Estimate for ImmunoGen, Inc. Issued By Jefferies Financial Group (NASDAQ:IMGN)
3 December, 2021 by The TZ Newswire Staff Comments Off on First Financial Bankshares (NASDAQ:FFIN) Upgraded by Zacks Investment Research to Buy
First Financial Bankshares (NASDAQ:FFIN) Upgraded by Zacks Investment Research to Buy
Zacks Investment Research upgraded shares of Evaxion Biotech A/S (NASDAQ:EVAX) from a hold rating to a buy rating in a report released on Tuesday, Zacks.com report